African Americans with cancer face many challenges to their care. Clinical trials can offer these patients life-saving options, and their participation can provide researchers and clinicians with a better understanding of their disease and treatment strategies. However, Black patients only represent 5 percent of trial participants despite making up 15 percent of cancer patients. More needs to be done to connect them to current scientific studies. A diverse and inclusive policy strategy for recruiting these patients can lead to higher rates of enrollment in clinical trials and better overall outcomes.

Read More